A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
The new micro-device for fluid analysis will enable more tailored experiments in drug development and disease research.
It could also transform water contamination testing and medical diagnosis in natural disaster zones, where its low cost, simple use and portability make it a practical tool almost anyone can use.
How it works
Microfluidic or ‘lab-on-a-chip’ devices are commonly used to analyse blood and other fluid samples, which are pumped through narrow channels in a transparent chip the size of a postage stamp.
These miniaturised chips are made using state-of-the-art device fabrication facilities at RMIT’s Micro Nano Research Facility.
This new chip takes that technology one step further by adding a three-dimensional cavity along the channel – think of a narrow tunnel that suddenly opens into a domed vault – which creates a mini-vortex where particles spin around, making them easier to observe.
To make this cavity, researchers inserted a liquid metal drop onto the silicon mould when making the chip.
The liquid metal’s high surface tension means it holds its form during the moulding process.
Finally the liquid metal is removed, leaving just the channel and a spherical cavity ready to use as a mini-centrifuge, explained RMIT engineer and study co-leader Dr Khashayar Khoshmanesh.
“When the fluid sample enters the spherical-shaped cavity, it spins inside the cavity,” he said.
“This spinning creates a natural vortex, which just like a centrifuge machine in an analytics lab, spins the cells or other biological samples, allowing them to be studied without the need for capturing or labelling them.”
The device only requires tiny samples, as little as 1 ml of water or blood, and can be used to study tiny bacterial cells measuring just 1 micron, all the way up to human cells as large as 15 microns.
A platform for studying cardiovascular diseases
Study co-leader and RMIT Postdoctoral Research Fellow, Dr Sara Baratchi, said the device’s soft spherical cavities could be used to mimic 3D human organs and observe how cells behave in various flow conditions or drug interactions.
“The ability to tailor the size of the cavity also allows for different flow situations to be simulated – this way we can mimic the response of blood cells under disturbed flow situations, for example at branch points and curvatures of coronary and carotid arteries, which are more prone to narrowing,” she said.
This capability will be of interest to Australia’s booming biomedical industry, with medical apparatus being among our top 10 exports in 2018 and worth $3.2 billion.
Baratchi said the discovery was only made possible through collaboration, with technologists from the School of Engineering and mechano-biologists in the School of Health and Biomedical Sciences joining forces in RMIT’s Mechanobiology and Microfluidics research group.
“Biologists like myself have been struggling to study the impact of flow-associated forces on circulatory blood cells. Now this miniaturised device developed with our engineering colleagues does exactly that,” Baratchi said.
“It’s an ingenious solution that really highlights the value of cross-disciplinary research.”
But some of the most exciting applications could also be outside the lab.
A cheap and portable water test that anyone can use
Another promising application is for identifying parasites and other infections in waterways, especially in developing countries.
“Detection of water impurities can be a difficult task because you don’t always know exactly what you’re looking for,” Khoshmanesh said.
“But with this device the impurities will be captured and orbited by the vortex without any special sample preparation, saving time and money.”
Whether used for analysing water or blood samples, the low cost and portability of the device makes it attractive for a whole range of applications.
The same research group recently developed a pressure pump, made from latex balloons, to operate the device.
Unlike conventional pumps, which can be as large as a shoebox and cost thousands of dollars, theirs is low cost and portable.
“Simplicity is a very important parameter for our designs because that often translates to lower cost and great applicability outside the lab,” Khoshmanesh said.
“Our new microfluidic device, combined with our pump and a smartphone capable of capturing high-speed images, makes a low-cost, self-sufficient and entirely portable point-of-care diagnostics device.”
The Latest on: Point-of-care diagnostics device
via Google News
The Latest on: Point-of-care diagnostics device
- Rising Demand for Diagnostic Tools Fuels the Growing Medical Imaging Marketon April 6, 2021 at 5:50 am
With the industry likely to grow to $43.33 billion by 2027, top medical imaging device manufacturers like Perimeter ... are taking note and developing point-of-care diagnostic tools for the US market.
- Point-of-Care or Rapid Testing Market Features of Investment Opportunities, Market Share & Future Trends to 2027: Roche, Abbott, Johnson & Johnsonon April 5, 2021 at 7:11 am
Medical device companies are facing difficulties in operating their ... A holistic market report for the Point-of-Care or Rapid Testing market is created in the final presentation. You will understand ...
- Co-Diagnostics CEO Egan says individuals and organizations will need DIY coronavirus tests partnered with vaccines to return to normalcyon April 1, 2021 at 3:51 pm
Co-Diagnostics expects to be prepared for the future with the next generation of gold-standard PCR devices and tests for at-home and point-of-care settings.” The Company is a publisher. You understand ...
- Health Logic Interactive Inc., Acquires Next-Generation Lab-On-Chip Medical Diagnostic Technologyon April 1, 2021 at 6:00 am
PRNewswire/ - Health Logic Interactive Inc. ("Health Logic" or the "Company") (TSXV: CHIP.H) (OTCPK: FNNGF), is pleased to announce its wholly owned ...
- Group K Diagnostics Announces the Appointment of A New Board Member and the Creation of a Scientific Advisory Boardon March 31, 2021 at 6:48 am
PHILADELPHIA, March 31, 2021 /PRNewswire/ -- Group K Diagnostics announced today the appointment of Dr. Jay Rosan to the board of directors. Dr. Rosan is a family physician and serial ...
- Point-Of-Care Cholesterol Monitoring Device Market To Set Phenomenal Growth In Key Regions By 2020–2027on March 31, 2021 at 12:40 am
The global Point-Of-Care Cholesterol Monitoring Device Market research report, recently added by Value Market Research, is entailed of various market parameters including market outlook, share, trends ...
- Point-of-Care Optics Design for Testing Infectious Diseaseson March 30, 2021 at 5:00 pm
In either setting, each user is utilizing a point-of-care test with actionable results. Likewise, if the device is a complex system (such as a modern high-throughput molecular diagnostic system like a ...
- MatMaCorp Launches MYRTA, a New Hand-Held Real-Time PCR Device for POC and OTC Molecular Diagnosticson March 30, 2021 at 6:00 am
“Almost all of the current handheld molecular diagnostic solutions have focused on isothermal ... Efforts at developing easy-to-use and affordable over-the-counter (OTC) and point-of-care (POC) ...
- BrainScope launches next-gen concussion diagnostic deviceon March 25, 2021 at 10:36 am
BrainScope announced that it launched its third FDA-cleared algorithm for concussion diagnosis on the BrainScope device.
- Co-Diagnostics Stock Is an Out-and-Out Buy Before the Earnings Releaseon March 25, 2021 at 8:27 am
In reference to this, Co-Diagnostics recently announced “the development of a new point-of-care/at home PCR [polymerase ... This small, cube-shaped device is designed to perform Covid-19 testing ...
via Bing News